The FDA has approved bemotrizinol as a new active ingredient for over-the-counter sunscreens, marking the first such approval in more than 25 years. Known as BEMT, this ingredient has been widely used in Europe and Asia since the 1990s, offering effective sun protection. Its recent authorization in the U.S. allows manufacturers to incorporate a well-established UV filter into their products, potentially enhancing the safety and effectiveness of sunscreen options for American consumers.
This development represents a significant advancement in personal care, reflecting evolving regulatory standards and scientific evaluation. Experts, including dermatologist Dr. Rachel Nazarian, have discussed the benefits and safety of bemotrizinol, emphasizing its established track record. As new sunscreens containing BEMT become available, users can expect improved formulations that align with the latest sun protection technologies.